Stock Performance Review on Cerner and Three Other Healthcare Information Services Stocks

Stock Research Monitor: COTV, INOV, and MDSO

LONDON, UK / ACCESSWIRE / June 7, 2018 / If you want a free Stock Review on CERN sign up now at www.wallstequities.com/registration. On Wednesday, the NASDAQ Composite ended the day at 7,689.24, up 0.67%; the Dow Jones Industrial Average edged 1.40% higher, to finish at 25,146.39; and the S&P 500 closed at 2,772.35, marginally gaining 0.86%. Gains were broad based as eight out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Healthcare Information Services stocks: Cerner Corp. (NASDAQ: CERN), Cotiviti Holdings Inc. (NYSE: COTV), Inovalon Holdings Inc. (NASDAQ: INOV), and Medidata Solutions Inc. (NASDAQ: MDSO). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Cerner

North Kansas City, Missouri headquartered Cerner Corp.’s stock finished Wednesday’s session 1.52% higher at $61.31 with a total trading volume of 1.63 million shares. The stock has gained 5.60% in the past month. The Company’s shares are trading above their 50-day moving average by 4.57%. Moreover, shares of Cerner, which provides health care information technology solutions and services in the US and internationally, have a Relative Strength Index (RSI) of 61.54. Get the full research report on CERN for free by clicking below at:

www.wallstequities.com/registration/?symbol=CERN

Cotiviti Holdings

Shares in Atlanta, Georgia headquartered Cotiviti Holdings Inc. declined 3.19%, ending yesterday’s session at $38.60 with a total trading volume of 1.34 million shares, which was higher than their three months average volume of 400.35 thousand shares. The stock has gained 15.22% in the past month and 11.88% in the previous three months. The Company’s shares are trading above their 50-day and 200-day moving averages by 12.99% and 13.35%, respectively. Moreover, shares of Cotiviti, which through its subsidiaries, provides analytics-driven payment accuracy and spend management solutions primarily for the healthcare sector in the US, Canada, the UK, and India, have an RSI of 71.99. Gain free access to the research report on COTV at:

www.wallstequities.com/registration/?symbol=COTV

Inovalon Holdings

On Wednesday, Bowie, Maryland headquartered Inovalon Holdings Inc.’s stock saw a rise of 0.47%, to close the day at $10.60. A total volume of 262,907 shares was traded. The stock is trading above its 50-day moving average by 1.99%. Additionally, shares of Inovalon, which provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry, have an RSI of 56.44. Register for your free report coverage on INOV at:

www.wallstequities.com/registration/?symbol=INOV

Medidata Solutions

Shares in New York headquartered Medidata Solutions Inc. ended the day 1.14% higher at $80.94. A total volume of 413,281 shares was traded. The stock has gained 18.98% in the previous three months. The Company’s shares are trading above their 50-day and 200-day moving averages by 12.66% and 14.57%, respectively. Furthermore, shares of Medidata Solutions, which provides cloud-based solutions for life sciences worldwide, have an RSI of 74.08.

On May 21st, 2018, research firm Morgan Stanley downgraded the Company’s stock rating from ‘Overweight’ to ‘Equal-Weight’. Get the free research report on MDSO at:

www.wallstequities.com/registration/?symbol=MDSO

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 501979